Celvestrant PFS Injection

Composition Fulvestrant (250mg)
Rx Prescription Required
Pack prefilled syringe of 5 ml Injection
Storage Store in a refrigerator (2 – 8°C). Do not freeze.
Chemical Class Estrogens Derivatives
Action Class Estrogen receptor antagonist
Habbit Forming No
Manufacturer Celon Laboratories Ltd
Manufacturer address Plot No 264, Patrika Nagar Madhapur, Hitech City Hyderabad, Telangana India – 500081

Celvestrant PFS Injection is given as an injection into the muscles under the supervision of a doctor. It should be taken as doctor your doctor’s advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include injection site reaction, headache, vomiting, allergic reaction, and nausea. If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.

Before taking this medicine, tell your doctor if you ever had kidney or liver disease or had bleeding disorder or had any blood clotting medicine. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

Breast cancer

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Celvestrant PFS Injection blocks the action of estrogen on breast cancer cells. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.

If you miss a dose of Celvestrant PFS Injection, please consult your doctor.

Celvestrant PFS Injection is used for the treatment of hormone dependent breast cancer.

It should only be taken by women who have undergone menopause and cannot become pregnant.

It is given as a slow injection into the muscles (intramuscular) of your buttock.

Inform your doctor if you have any bleeding disorder, kidney or liver disease or if you are receiving any medicines to prevent blood clots.

Do not take Celvestrant PFS Injection if you are pregnant or breastfeeding.

Q. What is Celvestrant PFS Injection and what is it used for?

Celvestrant PFS Injection contains a medicine, Fulvestrant which is used to treat breast cancer in women who have gone through menopause.

Q. How and in what dose should I use Celvestrant PFS Injection?

Your doctor would advise you the exact dose of this medicine. It is given as a slow (1 to 2 minutes) intramuscular (deep into the muscle) injection in your buttocks. It is administered by a medical healthcare professional only.

Q. What are the common side effects of using Celvestrant PFS Injection?

The common side effects associated with this medicine are headache, vomiting, urinary tract infection, diarrhea, vaginal bleeding, low platelets count and back pain. If any of these side effects bother you, consult with your doctor.

In Breast cancer

Celvestrant PFS Injection relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on the cancer to stop its growth. It is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Diarrhea

Urinary tract infection

Injection site reaction

Nausea

Allergic reaction

Weakness

Vomiting

Headache

Alcohol:CAUTION

Caution is advised when consuming alcohol with Celvestrant PFS Injection. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Celvestrant PFS Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding:UNSAFE

Celvestrant PFS Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving:SAFE

Celvestrant PFS Injection does not usually affect your ability to drive.

Kidney:CAUTION

Celvestrant PFS Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Celvestrant PFS Injection may be needed. Please consult your doctor.Limited information is available on the use of Celvestrant PFS Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.

Liver:CAUTION

Celvestrant PFS Injection should be used with caution in patients with liver disease. Dose adjustment of Celvestrant PFS Injection may be needed. Please consult your doctor.

Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.

Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1759-60.

Drugs.com. Fulvestrant. view

Fulvestrant. Luton, Bedfordshire: AstraZeneca UK Limited; 2004 . view

Fulvestrant. Cheshire, England: AstraZeneca UK Limited; 2002 . view

Central Drugs Standard Control Organisation . view